UK introduces new meningitis C vaccineBMJ 1999; 319 doi: https://doi.org/10.1136/bmj.319.7205.278 (Published 31 July 1999) Cite this as: BMJ 1999;319:278
- Jacqui Wise
A vaccination programme against meningococcal group C infection is to start this October in the United Kingdom in a bid to halve the total number of deaths from meningitis. The United Kingdom will be the first country in the world to implement such a vaccination programme following the development of a new meningitis C vaccine.
The new vaccine, unlike the existing one, provides long term protection and can be used in babies and young children. The meningococcal surface polysaccharide is conjugated with a protein using similar technology to that used for the first time with the haemophilus influenzae type b (Hib) vaccine.
Three manufacturers have developed the vaccine. One has submitted a licence application with the Medicines Control Agency and …
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.